摘要
目的探讨过氧化物酶体增殖物激活受体γ(PPAR-γ)激动剂罗格列酮对ANP大鼠肺损伤的作用及其机制。方法雄性Wistar大鼠54只,按完全随机法分为假手术组(SO组)、ANP组、罗格列酮组。胆胰管逆行注射5%牛磺胆酸钠制备ANP模型。SO组、ANP组在造模前30min股静脉注射10%DMSO(0.2ml/100g体重);罗格列酮组则注射等量10%DMSO溶解的罗格列酮(6mg/kg体重)。术后3h、6h、12h分批剖杀,每个时间点6只。检测血清淀粉酶、肺组织髓过氧化物酶(MPO)、肺湿干重比、支气管肺泡灌洗液(BALF)蛋白含量。取胰头部胰腺组织和肺组织行病理学检查。RT—PCR检测肺组织TNF-α mRNA和ICAM-1 mRNA的表达。结果ANP组血淀粉酶、肺MPO、湿干重比、BALF蛋白含量、胰腺及肺病理分值、肺脏TNF-α mRNA和ICAM-1 mRNA的表达水平均随时间延长而逐渐升高,12h时分别为(5353.0±728.2)U/L、(1.12±0.14)U/g、3.00±0.14、(0.438±0.056)g/L、11.17±0.93、8.17±0.75、0.57±0.03和1.53±0.08,均明显高于SO组(P〈0.05或P〈0.01)。罗格列酮12h组上述指标分别为(2847.4±841.0)U/L、(0.84±0.06)U/g、2.13±0.36、(0.283±0.078)g/L、7.75±0.27和4.33±0.82、0.26±0.04和0.84±0.02,均明显低于ANP 12h组(P〈0.05或P〈0.01),但仍高于SO组(P〈0.05或P〈0.01)。结论罗格列酮对ANP大鼠胰腺及肺损伤具有一定程度保护作用,其机制可能与抑制肺组织TNF-α、ICAM-1 mRNA的表达有关。
Objective To investigate the effect of Rosiglitazone on acute necrotizing pancreatitis (ANP) associated lung injury in rats and its potential mechanism. Methods Fifty-four male Wistar rats were randomly divided into sham operation group (SO group) , ANP group and Rosiglitazone pretreatment group (Rosi group). ANP model was induced by retrograde infusion of 5% sodium taurocholate into the biliopanereatic duct. The rats of SO group, ANP group were injected with 10% dimethyl sulfoxide (DMSO) (0. 2 ml/100 g) via femoral vein 30 minutes prior to the operation. In Rosi group Rosiglitazone partes aequales (6 mg/kg) , which was dissolved in 10% DMSO, was injected. Rats were killed at 3 h, 6 h and 12 h after induction. The serum amylase, lung myeloperoxidase (MPO) , lung wet/dry (W/D) weight ratio, protein content of bronchoalveolar lavage fluids (BALF) were measured, and pancreas and lung pathologic changes were evaluated. RT-PCR was used for detecting the levels of TNF-α and ICAM-1 mRNA in lung tissue. Results In ANP group, the values a of serum amylase, MPO, W/D weight ratio, protein content of BALF, pancreas and lung pathologic score, lung TNF-α and ICAM-1 mRNA expression increased corresponding to the duration of ANP course, and the corresponding values at 12 h were (5353.0±728.2) U/L, (1.12 ±0.14) U/g, 3.00 ±0.14, 0. 438 ± 0. 056, 11.17±0.93 and 8.17 ±0.75, respectively, which were significantly higher than those in the SO group (P 〈0.05 or P 〈0.01 ). The corresponding values in the Rosi group were (2847.4 ± 841 ) U/L, (0.84±0.06) U/g, 2.13±0.36, 0.283±0.078 g/L, 7.75±0.27, 4.33±0.82, 0.26±0.04 and 0.84±0.02, respectively, which were significantly higher than those in the SO group (P 〈 0.05 or P 〈 0.01 ). Conclusions Rosiglitazone had protective effect on lung injuries in ANP rats through down-regulating the expression of TNF-α and ICAM-1 mRNA.
出处
《中华胰腺病杂志》
CAS
2008年第5期329-332,共4页
Chinese Journal of Pancreatology